Compare $IMUC vs $INTS | Chartloom

Compare

$IMUC vs $INTS

Eom Pharmaceutical Holdings Inc · Intensity Therapeutics Inc

IMUC

Eom Pharmaceutical Holdings Inc

INTS

Intensity Therapeutics Inc

Compare $IMUC vs $INTS

Comparing Eom Pharmaceutical Holdings Inc and Intensity Therapeutics Inc

IMUCEom Pharmaceutical Holdings Inc

INTSIntensity Therapeutics Inc

IMUCEom Pharmaceutical Holdings Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-51.3%

52W performance

-31.7%

FCF yield

-18.9%

INTSIntensity Therapeutics Inc

Market cap

$10M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-64.3%

52W performance

-49.1%

FCF yield

-91.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMUC

INTS

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

INTS

Intensity Therapeutics Inc

Market Cap

IMUC$12M

INTS$10M

Enterprise Value

IMUC$14M

INTS$272K

Price

IMUC$0.10

INTS$3.63

P/E Ratio

IMUCN/A

INTSN/A

P/S Ratio

IMUC0.00x

INTS0.00x

EV/Sales

IMUC0.00x

INTS0.00x

EV/EBITDA

IMUC0.00x

INTS0.00x

P/B Ratio

IMUC3.51x

INTS1.22x

P/FCF Ratio

IMUCN/A

INTSN/A

EV/FCF

IMUC-6.11x

INTS-0.03x

PEG Ratio

IMUCN/A

INTSN/A

Forward P/E (NTM)

IMUCN/A

INTSN/A

Forward P/S (NTM)

IMUCN/A

INTSN/A

Revenue (TTM)

IMUC$0

INTS$0

Revenue Growth (YoY)

IMUCN/A

INTSN/A

Forward Rev Growth

IMUC0.0%

INTS506.0%

Gross Margin (TTM)

IMUC0.0%

INTS0.0%

Operating Margin (TTM)

IMUC0.0%

INTS0.0%

EBITDA Margin (TTM)

IMUC0.0%

INTS0.0%

Net Margin (TTM)

IMUC0.0%

INTS0.0%

FCF Margin (TTM)

IMUCN/A

INTSN/A

Net Income (TTM)

IMUC$-6M

INTS$-11M

FCF (TTM)

IMUC$-2M

INTS$-9M

EPS (TTM)

IMUC-$0.05

INTS-$4.12

ROE (TTM)

IMUC-4502.0%

INTS-11661.0%

ROA (TTM)

IMUC-45737.0%

INTS-9401.0%

ROIC (TTM)

IMUC-4502.0%

INTS-11661.0%

Cash

IMUC$933K

INTS$10M

Debt

IMUC$3M

INTS$0

Net Cash/Debt

IMUC$-2M

INTS$10M

Current Ratio (TTM)

IMUC1.51x

INTS5.00x

Quick Ratio (TTM)

IMUC1.28x

INTS4.24x

Debt/Equity (TTM)

IMUC0.00x

INTS0.00x

Debt/Assets (TTM)

IMUC0.0%

INTS0.0%

Interest Coverage (TTM)

IMUCN/A

INTSN/A

Net Debt/EBITDA (TTM)

IMUC0.00x

INTS0.00x

Beta

IMUC0.80

INTS3.02

52W Performance

IMUC-31.7%

INTS-49.1%

YTD Performance

IMUC-51.3%

INTS-64.3%

% from 52W High

IMUC-72.1%

INTS-91.7%

% from 52W Low

IMUC375.0%

INTS13.1%

Asset Turnover (TTM)

IMUC0.00x

INTS0.00x

FCF Yield (TTM)

IMUC-18.9%

INTS-91.4%

Earnings Yield (TTM)

IMUC-49.4%

INTS-113.9%

Dividend Yield (TTM)

IMUCN/A

INTSN/A

Rule of 40

IMUC0.0

INTS0.0

EV/GP/RG

IMUCN/A

INTSN/A

Ticker research

View IMUC research View INTS research

Metric	IMUC Eom Pharmaceutical Holdings Inc	INTS Intensity Therapeutics Inc
Market & Valuation
Market Cap	$12M	$10M
Enterprise Value	$14M	$272K
Price	$0.10	$3.63
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	1.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	-0.03x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	506.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-11M
FCF (TTM)	$-2M	$-9M
EPS (TTM)	-$0.05	-$4.12
ROE (TTM)	-4502.0%	-11661.0%
ROA (TTM)	-45737.0%	-9401.0%
ROIC (TTM)	-4502.0%	-11661.0%
Financial Health
Cash	$933K	$10M
Debt	$3M	$0
Net Cash/Debt	$-2M	$10M
Current Ratio (TTM)	1.51x	5.00x
Quick Ratio (TTM)	1.28x	4.24x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	3.02
52W Performance	-31.7%	-49.1%
YTD Performance	-51.3%	-64.3%
% from 52W High	-72.1%	-91.7%
% from 52W Low	375.0%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-18.9%	-91.4%
Earnings Yield (TTM)	-49.4%	-113.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View INTS research

Valuation

P/S Ratio

IMUC

0.00x

INTS

0.00x

EV/FCF

IMUC

-6.11x

INTS

-0.03x

Growth & revenue

Forward Revenue Growth

INTS

506.0%

IMUC

0.0%

Profitability & performance

Gross Margin

IMUC

0.0%

INTS

0.0%

ROE

IMUC

-4502.0%

INTS

-11661.0%

FCF Yield %

IMUC

-18.9%

INTS

-91.4%

52-Week Performance

IMUC

-31.7%

INTS

-49.1%

Detailed metrics comparison

IMUC

Eom Pharmaceutical Holdings Inc

INTS

Intensity Therapeutics Inc

Market Cap

IMUC$12M

INTS$10M

Enterprise Value

IMUC$14M

INTS$272K

Price

IMUC$0.10

INTS$3.63

P/E Ratio

IMUCN/A

INTSN/A

P/S Ratio

IMUC0.00x

INTS0.00x

EV/Sales

IMUC0.00x

INTS0.00x

EV/EBITDA

IMUC0.00x

INTS0.00x

P/B Ratio

IMUC3.51x

INTS1.22x

P/FCF Ratio

IMUCN/A

INTSN/A

EV/FCF

IMUC-6.11x

INTS-0.03x

PEG Ratio

IMUCN/A

INTSN/A

Forward P/E (NTM)

IMUCN/A

INTSN/A

Forward P/S (NTM)

IMUCN/A

INTSN/A

Revenue (TTM)

IMUC$0

INTS$0

Revenue Growth (YoY)

IMUCN/A

INTSN/A

Forward Rev Growth

IMUC0.0%

INTS506.0%

Gross Margin (TTM)

IMUC0.0%

INTS0.0%

Operating Margin (TTM)

IMUC0.0%

INTS0.0%

EBITDA Margin (TTM)

IMUC0.0%

INTS0.0%

Net Margin (TTM)

IMUC0.0%

INTS0.0%

FCF Margin (TTM)

IMUCN/A

INTSN/A

Net Income (TTM)

IMUC$-6M

INTS$-11M

FCF (TTM)

IMUC$-2M

INTS$-9M

EPS (TTM)

IMUC-$0.05

INTS-$4.12

ROE (TTM)

IMUC-4502.0%

INTS-11661.0%

ROA (TTM)

IMUC-45737.0%

INTS-9401.0%

ROIC (TTM)

IMUC-4502.0%

INTS-11661.0%

Cash

IMUC$933K

INTS$10M

Debt

IMUC$3M

INTS$0

Net Cash/Debt

IMUC$-2M

INTS$10M

Current Ratio (TTM)

IMUC1.51x

INTS5.00x

Quick Ratio (TTM)

IMUC1.28x

INTS4.24x

Debt/Equity (TTM)

IMUC0.00x

INTS0.00x

Debt/Assets (TTM)

IMUC0.0%

INTS0.0%

Interest Coverage (TTM)

IMUCN/A

INTSN/A

Net Debt/EBITDA (TTM)

IMUC0.00x

INTS0.00x

Beta

IMUC0.80

INTS3.02

52W Performance

IMUC-31.7%

INTS-49.1%

YTD Performance

IMUC-51.3%

INTS-64.3%

% from 52W High

IMUC-72.1%

INTS-91.7%

% from 52W Low

IMUC375.0%

INTS13.1%

Asset Turnover (TTM)

IMUC0.00x

INTS0.00x

FCF Yield (TTM)

IMUC-18.9%

INTS-91.4%

Earnings Yield (TTM)

IMUC-49.4%

INTS-113.9%

Dividend Yield (TTM)

IMUCN/A

INTSN/A

Rule of 40

IMUC0.0

INTS0.0

EV/GP/RG

IMUCN/A

INTSN/A

Ticker research

View IMUC research View INTS research

Metric	IMUC Eom Pharmaceutical Holdings Inc	INTS Intensity Therapeutics Inc
Market & Valuation
Market Cap	$12M	$10M
Enterprise Value	$14M	$272K
Price	$0.10	$3.63
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.51x	1.22x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.11x	-0.03x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	506.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-11M
FCF (TTM)	$-2M	$-9M
EPS (TTM)	-$0.05	-$4.12
ROE (TTM)	-4502.0%	-11661.0%
ROA (TTM)	-45737.0%	-9401.0%
ROIC (TTM)	-4502.0%	-11661.0%
Financial Health
Cash	$933K	$10M
Debt	$3M	$0
Net Cash/Debt	$-2M	$10M
Current Ratio (TTM)	1.51x	5.00x
Quick Ratio (TTM)	1.28x	4.24x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	3.02
52W Performance	-31.7%	-49.1%
YTD Performance	-51.3%	-64.3%
% from 52W High	-72.1%	-91.7%
% from 52W Low	375.0%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-18.9%	-91.4%
Earnings Yield (TTM)	-49.4%	-113.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMUC research	View INTS research